神经刺激设备市场规模、份额、成长分析（按产品、应用和地区）- 2025 年至 2032 年产业预测

Neurostimulation Devices Market Size, Share, and Growth Analysis, By Product (Spinal Cord Stimulator, Deep Brain Stimulator), By Application (Pain Management, Epilepsy), By Region - Industry Forecast 2025-2032

出版日期: 2025年04月02日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2023 年神经刺激设备市场规模价值 59.8 亿美元，预计将从 2024 年的 67.5 亿美元成长到 2032 年的 176.8 亿美元，预测期内（2025-2032 年）的复合年增长率为 12.8%。

由于神经系统疾病病例的增加以及全球对相关研究的投资增加，神经刺激设备市场预计将显着成长。人们对神经系统疾病的认识不断提高，对有效治疗的需求不断增加，为该领域的提供者创造了充足的机会。广泛研究带来的技术进步正在加强神经刺激设备的销售，而对微创手术的偏好进一步推动了市场需求。优惠的报销政策和对神经刺激益处的认识不断提高也创造了新的商机。然而，併发症风险、设备成本高以及熟练专业人员短缺等挑战可能会在短期内阻碍市场成长。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业市场定位（2024年）
主要市场参与者所采取的策略
近期市场趋势
公司市场占有率分析（2024年）
主要企业简介
- 公司详情
- 产品系列分析
- 公司分部份额分析
- 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

Medtronic（Ireland）
Abbott Laboratories（USA）
Boston Scientific Corporation（USA）
Nevro Corporation（USA）
LivaNova PLC（UK）
NeuroPace, Inc.（USA）
Neuronetics, Inc.（USA）
Axonics Modulation Technologies, Inc.（USA）
Cochlear Limited（Australia）
ElectroCore, Inc.（USA）
Aleva Neurotherapeutics SA（Switzerland）
Soterix Medical（USA）
Bioinduction（United Kingdom）
Oticon Medical（Denmark）

结论和建议

简介目录

Product Code: SQMIG35B2087

Neurostimulation Devices Market size was valued at USD 5.98 billion in 2023 and is poised to grow from USD 6.75 billion in 2024 to USD 17.68 billion by 2032, growing at a CAGR of 12.8% during the forecast period (2025-2032).

The neurostimulation devices market is poised for significant growth driven by an increase in neurological disorder cases and heightened investments in related research globally. Rising awareness of neurological diseases and an increasing demand for effective treatments are creating ample opportunities for providers in this sector. Technological advancements from extensive research are set to enhance the sales of neurostimulation devices, while the preference for minimally invasive surgical procedures further supports market demand. Favorable reimbursement policies and growing recognition of the benefits of neurostimulation also present new business opportunities. However, challenges such as the risks of complications, high device costs, and a lack of skilled professionals may hinder market growth in the foreseeable future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Neurostimulation Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Neurostimulation Devices Market Segments Analysis

Global Neurostimulation Devices Market is segmented by Product, Application and region. Based on Product, the market is segmented intoSpinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator and Gastric Electric Stimulator. Based on Application, the market is segmented into Pain Management, Epilepsy, Essential Tremor, Urinary & Fecal Incontinence, Depression, Dystonia, Gastroparesis, Parkinson's Disease and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Neurostimulation Devices Market

The rising prevalence of neurological disorders has been greatly influenced by unhealthy lifestyle choices and the widespread adoption of detrimental habits. As the incidence of conditions such as Parkinson's disease, epilepsy, chronic pain, and depression continues to escalate, there is a correspondingly high demand for neurostimulation devices. These devices are essential in the management and treatment of various neurological ailments, making them vital for improving patient outcomes. Consequently, the increasing recognition of neurostimulation's effectiveness in alleviating symptoms and enhancing quality of life drives the market forward, underscoring the urgent need for innovative solutions in neuromodulation therapy.

Restraints in the Neurostimulation Devices Market

The neurostimulation devices market is grappling with a significant restraint due to the reliance on highly advanced medical technology, which necessitates the expertise of highly trained professionals for effective operation. Unfortunately, the current global landscape is experiencing a shortage of skilled healthcare providers, a trend that also adversely affects the neurostimulation sector. This lack of qualified personnel poses a potential barrier to the market's growth and development, as the limited availability of trained medical professionals may hinder the widespread adoption and utilization of these sophisticated devices, ultimately impacting their market expansion prospects in the future.

Market Trends of the Neurostimulation Devices Market

The neurostimulation devices market is increasingly embracing the trend of personalized medicine, reflecting a global shift towards tailored healthcare solutions. As awareness of individualized treatment options grows, these devices are being designed to adapt to the unique neurological patterns of patients, enhancing therapeutic effectiveness for conditions such as chronic pain and epilepsy. This customization not only improves patient outcomes but also fosters greater patient engagement and satisfaction. As technological advancements continue to unfold, the demand for such personalized neurostimulation solutions is expected to surge, positioning them as a pivotal component in the future landscape of neuromodulation therapies.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Analysis

Global Neurostimulation Devices Market Size by Product & CAGR (2025-2032)

Market Overview
Spinal Cord Stimulator
Deep Brain Stimulator
Sacral Nerve Stimulator
Vagus Nerve Stimulator
Gastric Electric Stimulator

Global Neurostimulation Devices Market Size by Application & CAGR (2025-2032)

Market Overview
Pain Management
Epilepsy
Essential Tremor
Urinary & Fecal Incontinence
Depression
Dystonia
Gastroparesis
Parkinson's Disease
Others

Global Neurostimulation Devices Market Size & CAGR (2025-2032)

North America (Product, Application)
- US
- Canada
Europe (Product, Application)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Application)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Application)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Application)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nevro Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NeuroPace, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neuronetics, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Axonics Modulation Technologies, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cochlear Limited (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ElectroCore, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aleva Neurotherapeutics SA (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Soterix Medical (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioinduction (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oticon Medical (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments